Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline in Chinese Patients of Gynecologic Malignancies

NCT03740672 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT03740672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03740672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline in Chinese Patients of Gynecologic Malignancies
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
November 22, 2018
Completion date
December 1, 2019
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting, gynecologic cancer